Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
AtheroGenics (AGIX)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for AGIX as compared to
Top Competitors
Drug Manufacturers - Other
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
INCOME STATEMENT (
See all
)
Revenue
►
10.6M
AVG
EBITDA
►
-39.3M
AVG
Net Income
►
-59.9M
AVG
Revenue Growth
►
-83.2%
LOW
Operating Margin
►
-437%
AVG
Net Margin
►
-567.4%
AVG
Revenue, Gross Profit, and Gross Margin
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-1.33
Current Ratio
►
1.68
AVG
Quick Ratio
►
1.68
AVG
Interest Coverage Ratio
►
-3.35
AVG
Book Value Per Share
►
-1.41
Cash Per Share
►
0.406
Loading...
STOCK SUMMARY
No data.
VALUATION
Price to Earnings (P/E)
►
0
Price to Book (P/B)
►
0
Price to Sales (P/S)
►
0
Return on Assets (ROA)
►
-43.1%
AVG
Return on Equity (ROE)
►
30.7%
AVG
EV/EBITDA
►
-8.12
OWNERSHIP
No data.
No Sales Breakout Data.